Akshay Kumar, doctors, sportspersons laud PM Modi’s call to fight Obesity

New Delhi: Prime Minister Narendra Modi‘s call to combat obesity and reduce oil consumption has received widespread support from across the nation.  Speaking at the 38th National Games in Dehradun, he emphasised the importance of regular exercise, a balanced diet, and a 10 per cent reduction in daily oil consumption.

The call has been supported by doctors, sportspersons, and various public figures, including actor Akshay Kumar, according to the official statement.

The statement highlights that Prime Minister Narendra Modi recently gave a clarion call to fight obesity and reduce oil consumption. This has received wide support from doctors, sportspersons, and people from different walks of life.

According to an ANI report, during his address at the opening ceremony of the 38th National Games in Dehradun, the Prime Minister discussed how the problem of obesity is increasing rapidly in the country, which is a matter of concern because obesity increases the risk of diseases like diabetes and heart disease.

Also Read:Milestone: Genome data of 10,000 Indians available for research, says PM Modi

Talking about the Fit India Movement, he spoke about the importance of exercise and diet, with a focus on balanced intake. He underlined the importance of reducing unhealthy fat and oil in food and gave the novel suggestion of reducing daily oil consumption by 10%.

Actor Akshay Kumar praised the Prime Minister’s message and highlighted the importance of good health.

The health community has strongly supported PM Modi’s clarion call. The World Health Organization South-East Asia also endorsed the call for regular physical activity and a balanced nutritious diet.

The health fraternity has come out in huge numbers supporting the Prime Minister’s clarion call. The World Health Organisation South-East Asia highlighted the prime minister’s call for regular physical activity and a balanced nutritious diet.

In a statement, Gautam Khanna, CEO of P. D. Hinduja Hospital, called it a timely message on the importance of reducing obesity and associated risks. Harsh Mahajan, Founder & Chairman of Mahajan Imaging & Labs, lauded the Prime Minister’s call to action to fight against obesity, as stated in an official release.

Shuchin Bajaj, Founder and Director of Ujala Cygnus Healthcare Services, emphasised that obesity is a serious challenge that the country must tackle immediately and collectively. Various other doctors also spoke in support of the importance of addressing the obesity crisis. Several hospitals, medical bodies, and associations, including the Indian Dental Association, Tata Memorial Hospital, and the Endocrine Society of Delhi, have voiced their support for the movement against obesity, reports ANI.

Boxer Vijender Singh praised the campaign launched by PM Modi, focusing on balanced diet, exercise, and health.

Fitness coach Mickey Mehta and World Championship bronze medallist boxer Gaurav Bidhuri also backed the prime minister’s initiative.

Also Read:PM Modi lays foundation stone for Rs 185 crore Central Ayurveda Research Institute in Delhi

Powered by WPeMatico

212 seats available for NEET PG mop up round- DME Chhattisgarh Releases Revised Schedule, seat matrix

Chhattisgarh- Director of Medical Education (DME) Chhattisgarh has released the revised tentative schedule of National Eligibility and Entrance Test-Postgraduate (NEET PG) MD and MS Counselling Mop Up and Stray Vacancy Round for Chhattisgarh State Quota for the academic year 2024-25. The revised tentative schedule for CG State NEET PG Counselling 2024 has been released per the MCC schedule.

As per the revised tentative schedule, NEET PG Mop-Up Counselling 2024 already began on 31st January 2025, 11:00 AM and will end on 03rd February 2025, 11:59. The choice filling and locking process will end on 03 February 2025.

Also Read: Revised percentile cutoff- DME Chhattisgarh Releases state NEET PG Counselling 2024 Merit List

Thereafter, the seat allotment process will begin on 05 February 2025 and the result will be published on 06 February 2025. After this, the scrutiny and admission process (at the Institute) will start from 07 to 13 February 2025.

Meanwhile, NEET PG stray vacancy round counselling 2024 will begin from February 15, 2025, and end on February 23, 2025. In which the choice filling and locking process will start on February 15, 2025, which will end on February 17, 2025.

Thereafter, the seat allotment process will begin on 18th February 2025 and the result will be published on 19th February 2025. After this, the scrutiny and admission process (at the Institute) will start from 20 to 23 February 2025.

However, no fresh registration is needed for the NEET PG MD and MS Counselling Mop Up and Stray Vacancy Round for Chhattisgarh State Quota 2024-25. Also, no Merit list will be published in these two rounds for the candidates. Below is the complete revised tentative schedule-

REVISED TENTATIVE SCHEDULE

S.NO.

FRESH ONLINE REGISTRATIONS/FEE PAYMENT

CHOICE FILLING/LOCKING

MERIT LIST PUBLICATION

SEAT ALLOTMENT PROCESS

RESULT PUBLICATION

SCRUTINY PROCESS (AT INSTITUTE)

ADMISSION PROCESS (AT INSTITUTE)

MOP-UP ROUND

1

DAYS

31 January 2025 to 03 February 2025

05 February 2025

06 February 2025

07 to 13 February 2025 (1:00 pm)

07 to 13 February 2025 (5:00 pm)

(04-days)

(01-day)

(01-day)

(07-days)

(07-days)

STRAY VACANCY ROUND

2

15 to 17 February 2025

18 February 2025

19 February 2025

20 to 23 February 2025 (1:00 pm)

20 to 23 February 2025 (5:00 pm)

DAYS

(03-days)

(01-day)

(01-day)

(04-days)

(04-days)

STRAY VACANCY ROUND ELIGIBILITY

1 Candidates who were allotted a seat in the first or second round of NEET PG Medical counselling but did not take admission or opted for “Reject” in the first or second round.

2 Candidates who are registered but have not been allotted any seat in the previous rounds.

STRAY VACANCY ROUND IN-ELIGIBILITY

1 Candidates who have been allotted a seat in the Mop-up Round.

2 Candidates who have accepted their allotted seat in any round but have not completed the admission process.

3 Candidates who had accepted their allotted seats in the previous rounds, appeared for scrutiny but were declared ineligible.

SEAT MATRIX

Meanwhile, DME Chhattisgarh has also released the CG NEET PG Mop-Up Round Seat Matrix Session 2024-25. As per the Seat Matrix, a total of 212 seats are vacant across 9 Medical colleges of Chhattisgarh. Of these, Late Shri Lakhiram Aggarwal Memorial Medical College has the maximum number of 42 seats vacant and Bharat Ratna Late Shri Atal Bihari Vajpayee Memorial Medical College has the minimum number of 6 seats vacant.

S.NO

INSTITUTES

VACANT SEATS

1

PT. JAWAHAR LAL NEHRU MEMORIAL MEDICAL COLLEGE, RAIPUR.

34

2

CHHATTISGARH INSTITUTE OF MEDICAL SCIENCES, BILASPUR.

22

3

LATE BALIRAM KASHYAP SMRITI. MEDICAL COLLEGE, JAGDALPUR.

9

4

BHARAT RATNA LATE SHRI ATAL BIHARI VAJPAYEE MEMORIAL MEDICAL COLLEGE, RAJNANDGAON.

6

5

RAJMATA SMT. DEVENDRA KUMARI SINGHDEO GOVERNMENT MEDICAL COLLEGE, AMBIKAPUR.

13

6

SHRI SHANKARACHARYA INSTITUTE OF MEDICAL SCIENCE BHILAI.

38

7

RAIPUR INSTITUTE OF MEDICAL SCIENCES, RAIPUR.

37

8

LATE SHRI LAKHIRAM AGRAWAL MEMORIAL MEDICAL COLLEGE, RAIGARH.

11

9

LATE SHRI LAKHIRAM AGRAWAL MEMORIAL MEDICAL COLLEGE, RAIGARH.

42

TOTAL

212

To view the revised tentative schedule, click the link below

https://medicaldialogues.in/pdf_upload/dme-chhattisgarh-releases-revised-neet-pg-2024-counselling-schedule-for-mop-up-stray-vacancy-rounds-check-key-dates-here-272345.pdf

To view the vacant seat details, click the link below

https://medicaldialogues.in/pdf_upload/seat-matrix-272346.pdf

Powered by WPeMatico

NEET PG Counselling: DME Gujarat Begins Round 3 Choice Filling, 397 Seats Vacant

Gujarat- The Director of Medical Education (DME) Gujarat has started the 3rd round of the online choice-filling process for admission to MD/MS/Diploma courses in government and self-financed medical colleges for the academic year 2024-25.

As per the schedule in this regard, the 3rd round of the online choice-filling process for admission to MD/MS/Diploma courses 2024-25 started today i.e. 01st February 2025 which will end on 04 February 2025, 11:00 am. Following this, the choices filled by candidates will be displayed on 04 February 2025, 06:00 pm.

The candidates included in the Merit List of ACPPGMEC, for admission to Government Seats, Management Seats and NRI Seats of MD/MS/Diploma courses in Government and Self-financed Medical Colleges for the academic year 2024-25 are eligible for the 3rd round of online choice filling.

Also Read: 69 MD, MS, DNB seats vacant after Round 2 NEET PG counselling: DME Gujarat

Meanwhile, DME Gujarat has also released the MD, MS, Diploma and DNB round 03 vacant seat details for 2024-25. As per the vacant seat details, a total of 397 seats are vacant across 32 MD, MS, Diploma and DNB courses. Of these, a total of 381 seats are vacant across 21 MD and MS courses, a total of 8 seats are vacant across 5 Diploma courses and a total of 8 seats are vacant across 6 DNB Courses.

MD AND MS COURSES VACANT SEAT DETAILS

S.NO

SPECIALITY

VACANT SEATS

1

Anaesthesiology.

39

2

Biochemistry.

11

3

Community Medicine.

23

4

Dermatology, Venereology & Leprosy.

7

5

Emergency Medicine.

3

6

Forensic Medicine.

9

7

General Medicine.

31

8

Immuno Haematology & Blood Transfusion.

4

9

Microbiology.

18

10

Paediatrics.

17

11

Pathology.

28

12

Pharmacology.

15

13

Physiology.

26

14

Psychiatry.

10

15

Radio Diagnosis.

5

16

Tuberculosis & Respiratory Diseases.

16

17

Anatomy

28

18

General Surgery

28

19

Ophthalmology.

12

20

Orthopaedics.

18

21

Otorhinolaryngology/ENT.

14

TOTAL

381

DIPLOMA COURSES VACANT SEAT DETAILS

S.NO

SPECIALITY

VACANT SEATS

1

Diploma in Anesthesiology (D.A.).

2

2

Diploma in Clinical Pathology (D.C.P.)

2

3

Diploma in Community Medicine (D.C.M.)

1

4

Diploma in Obstetrics & Gynecology (D.G.O.).

2

5

Diploma in Public Health (D.P.H.).

1

TOTAL

8

DNB COURSES VACANT SEAT DETAILS

S.NO

SPECIALITY

VACANT SEATS

1

General Surgery (DNB).

1

2

Anesthesiology (DNB).

1

3

Pathology (DNB) 376

1

4

Diploma in Anesthesiology (D.A.)(DNB).

1

5

Diploma in Obstetrics & Gynecology (D.G.O.)(DNB).

3

6

Diploma in Radio-diagnosis (D.M.R.D.) (DNB).

1

TOTAL

8

To view the vacant seat details, click the link below

https://medicaldialogues.in/pdf_upload/dme-gujarat-begins-3rd-round-of-online-choice-filling-for-md-ms-diploma-admissions-2024-today-397-seats-vacant-272322.pdf

Powered by WPeMatico

Sun Pharma net profit rises 15 percent to Rs 2903 crore in Q3

New Delhi: Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for the December quarter, driven by strong sales across geographies.

In the same period last year, the company had posted a net profit of Rs 2,524 crore.

Total revenue from operations rose to Rs 13,675 crore in the third quarter compared to Rs 12,381 crore in the year-ago period, Sun Pharma said in a regulatory filing.
The company said its board has declared an interim dividend of Rs 10.5 per share for the year FY25 against Rs 8.50 per share interim dividend for the previous year.
According to PTI, Sun Pharma Chairman and Managing Director Dilip Shanghvi said, “Our performance in the quarter showed all-round improvement. Product sales in Global Specialty crossed 1/5th of overall sales,”
“Our market share gain in India has been driven by industry-leading volume growth. Emerging Markets demonstrated strong performance in spite of currency challenges across geographies,” he added.
All the company’s businesses remain well-positioned for the future, Shanghvi stated.
The Mumbai-based drug maker said its formulation sales in India stood at Rs 4,300 crore in the December quarter, a growth of 13.8 per cent over the same period last fiscal and accounting for around 32 per cent of total consolidated sales.
Formulation sales in the US were at USD 474 million for the third quarter, a marginal dip as compared with the third quarter of last fiscal and accounting for around 30 per cent of the total consolidated sales.
Formulation sales in the emerging markets stood at USD 277 million in the third quarter, a year-on-year growth of 10 per cent and accounting for around 17 per cent of total consolidated sales.
Similarly, formulation sales in the Rest of World (ROW) markets, excluding India, the US and Emerging Markets, stood at USD 259 million in Q3FY25, a year-on-year growth of 21 per cent against the preceding fiscal.
External sales of API (Active Pharmaceutical Ingredient) were Rs 568 crore in Q3FY25, growing by 21.8 per cent over Q3 last year.
Sun Pharma shares ended 0.12 per cent lower at Rs 1,743.10 apiece on the BSE.

Powered by WPeMatico

Does drinking alcohol really take away the blues? It’s not what you think

A new study from the University of Chicago Medicine reveals that people with alcohol use disorder (AUD) and depression experience high levels of stimulation and pleasure when intoxicated, similar to drinkers who do not have depression.

Powered by WPeMatico

Biomarker predicts KRASG12C inhibitor success in lung cancer treatment

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer Research, found that measuring the interaction between two proteins, RAS and RAF, could provide valuable insights into the effectiveness of treatments for patients with KRASG12C-mutant non-small cell lung cancer, a type of lung cancer known for being particularly difficult to treat.

Powered by WPeMatico

Prostate cancer study reveals early radiation side effects predict future issues

Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, according to a new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center.

Powered by WPeMatico

Researchers link India’s food program to better health and stronger incomes

Despite humanity’s scientific achievements and globalized economy, malnutrition remains a global issue. The United Nations estimated that 2.33 billion people experienced moderate or severe food insecurity in 2023.

Powered by WPeMatico

Watch what you eat: NFL game advertisements promote foods high in fat and sodium

Research from Saint Louis University (SLU) and the University of Nevada, Reno School of Medicine finds that some of the most-watched ads promote the worst food options for adults with chronic health conditions.

Powered by WPeMatico

Patients can file appeals against state medical councils orders: NMC

New Delhi: Considering patients’ rights, the National Medical Commission (NMC) has now decided to take up their appeals against state medical councils’ orders. Even though this provision was already there during the erstwhile Medical Council of India (MCI), since 2020, NMC, which replaced MCI, has been rejecting appeals by patients.

Relying on Section 30(3) of the NMC Act 2019, the Commission had time and again clarified that only doctors had the right to appeal against the State Medical Council’s rulings.

However, this scenario is soon going to change as NMC has now decided that all appeals received by the Ethics and Medical Registration Board (EMRB) will be entertained. NMC mentioned this decision in the minutes of the 16th meeting held on 23rd September 2024, a copy of which was shared with Dr. K V Babu, who filed an RTI application in this regard.

As per the document, a copy of which is with the Medical Dialogues team, the issue of taking a policy decision regarding the disposal of non-medico’s complaints not decided by the State Medical Councils within the prescribed time limit was an agenda of the 14th meeting of NMC Ethics Board.

Also Read: NMC norms don’t have option for appeals by patients, proposal pending at govt level

In this regard, NMC agreed that “all appeals received by EMRB will be entertained.”

Further, regarding the issue of action not being taken by state medical councils, SMCs on complaints filed by Non-medicos even after issuance of reminders by the boards, “It was decided to send a communication by EMRB to State Medical Councils to complete the process in a time bound manner.”

“In case of failure by the concerned SMC to act upon, EMRB may take over the complaint matter from the SMC and dispose the same. This is noted by EMRB, and board will proceed further accordingly,” the minutes of the 16th NMC meeting read. However, NMC’s decision to take up the patients’ appeals has not been made public yet.

Speaking to Medical Dialogues in this regard, Health Activist Dr. KV Babu, who has been raising the matter for a long time, said, “I welcome the decision of the NMC, though delayed. I had been repeatedly arguing that the patients have the right to appeal against the SMC decision under ethics regulation 2002, 8.8.”

Section 8.8 of the MCI Ethics Regulations 2002 states, “Any person aggrieved by the decision of the State Medical Council on any complaint against a delinquent physician, shall have the right to file an appeal to the MCI within a period of 60 days from the date of receipt of the order passed by the said Medical Council: Provided that the MCI may, if it is satisfied that the appellant was prevented by sufficient cause from presenting the appeal within the aforesaid period of 60 days, allow it to be presented within a further period of 60 days.”

“Happy that better sense prevailed,” added Dr. Babu, while thanking the NMC chairman, to whom Dr. Babu had approached with the matter. 

Medical Dialogues had earlier reported how NMC had turned down 65 appeals moved by patients or their families between March to September 2022 on the grounds of non-maintainability. The data came to light in response to an RTI application filed by Dr Babu back in 2022.

These appeals were rejected as per Section 30(3) of the NMC Act 2019 which states, “(3) A medical practitioner or professional who is aggrieved by any action taken by a State Medical Council under sub-section (2) may prefer an appeal to the Ethics and Medical Registration Board against such action, and the decision, if any, of the Ethics and Medical Registration Board thereupon shall be binding on the State Medical Council, unless a second appeal is preferred under sub-section (4).”

Back in 2023, the Central Government put the proposal to amend the NMC Act 2019 allowing the patients and their relatives to challenge the decisions of the State Medical Councils (SMCs) before the NMC Ethics Board on hold. This was revealed by the authorities in response to a Right to Information (RTI) application filed by Health Activist Dr. KV Babu. The proposal for amending the NMC Act 2019 was put forth by the Government itself.

Also Read: Proposal allowing Patients to appeal against State Medical Council Decisions to NMC gone on hold

Powered by WPeMatico